Monday, Chart Industries Inc. (GTLS) announced that CAIRE, which operates under Chart's BioMedical segment, has completed the previously announced acquisition of Covidien's (COV) oxygen therapy business, including the design, manufacturing, and sales and service functions worldwide. The acquisition includes products sold under the Companion and HELiOS brands. Financial terms of the transaction were not disclosed, the company said.
CAIRE is a respiratory care products provider for the home health care market, manufacturing a full line of liquid oxygen reservoirs and liquid oxygen portables sold under the Liberator and Spirit brands.
"We are pleased to have the Companion and HELiOS liquid oxygen therapy brands included in our product offering and look forward to selling and servicing these products under CAIRE. As previously mentioned, we expect to complete the integration of this business into CAIRE towards the end of 2010," stated Steve Shaw, President of Chart BioMedical Group.
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.